Statistik Asas
| LEI | 549300SN58QQ28RVWE26 |
| CIK | 1725255 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to AdaptHealth Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| August 5, 2025 |
FH 7.10] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 5, 2025 |
ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2025 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2025 RESULTS CONSHOHOCKEN, Pa. – August 5, 2025 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quar |
|
| August 5, 2025 |
Non-Employee Director Fee Deferral Policy, effective May 30, 2025. Exhibit 10.1 AdaptHealth Corp. Non-Employee Director Fee Deferral Policy Effective as of May 30, 2025 Pursuant to its authority under Section 3(d) of the Charter of the Compensation Committee of the Board of Directors of AdaptHealth Corp. (the “Company”), the Compensation Committee has adopted this Non-Employee Director Fee Deferral Policy (this “Policy”). Unless otherwise defined herein, capitali |
|
| August 5, 2025 |
Exhibit 99.1 ADAPTHEALTH CORP. FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. PARTNERS WITH A MAJOR NATIONAL HEALTHCARE SYSTEM TO BECOME THE EXCLUSIVE PROVIDER OF HOME MEDICAL EQUIPMENT CONSHOHOCKEN, Pa. – August 5, 2025 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medic |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 5, 2025 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Co |
|
| June 30, 2025 |
ADAPTHEALTH CORP. CLOSES TRANSACTION TO DISPOSE OF CERTAIN HOME INFUSION ASSETS AND REDUCES DEBT Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. CLOSES TRANSACTION TO DISPOSE OF CERTAIN HOME INFUSION ASSETS AND REDUCES DEBT CONSHOHOCKEN, Pa. – June 30, 2025 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announc |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2025 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of regist |
|
| May 28, 2025 |
May 28, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| May 6, 2025 |
ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2025 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2025 RESULTS CONSHOHOCKEN, Pa. – May 6, 2025 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter e |
|
| May 6, 2025 |
Exhibit 10.2 February 23, 2023 Re: Updated Employment Letter Dear Christie: It is my pleasure to provide documentation of your revised offer terms with AdaptHealth Corp. Any terms not addressed below will remain the same as those set out in your previous offer of employment: The key terms are as follows: 1.Position. You are being promoted to the position of Chief Accounting Officer with an effecti |
|
| May 6, 2025 |
Exhibit 10.1 August 15, 2022 Re: Offer of Employment Dear Christie: It is my pleasure to extend an offer of employment with AdaptHealth Corp. The key terms of this employment offer are as follows: 1.Position. You are offered the position of Senior Vice President, Accounting reporting to the Chief Financial Officer with a start date of on or around October 1, 2022. As an employee of AdaptHealth, Co |
|
| May 6, 2025 |
] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as speci |
|
| May 6, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 6, 2025 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Commi |
|
| April 30, 2025 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defi |
|
| February 25, 2025 |
Exhibit 21.1 The Company’s principal subsidiaries as of December 31, 2024 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. Subsidiaries (Alphabetically) State of Inc. ABC Medical, LLC SOUTH CAROLINA Absolute Respiratory Care, LLC RHODE ISLAND Access Medical, LLC MICHIGAN Accu |
|
| February 25, 2025 |
ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 RESULTS AND PROVIDES 2025 OUTLOOK Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 RESULTS AND PROVIDES 2025 OUTLOOK PLYMOUTH MEETING, Pa. – February 25, 2025 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announ |
|
| February 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specified in |
|
| February 25, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 25, 2025 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) |
|
| February 25, 2025 |
AdaptHealth Corp. Insider Trading Policy. Exhibit 19.1 ADAPTHEALTH CORP. INSIDER TRADING POLICY I.Introduction Ownership by the members of the Board of Directors of AdaptHealth Corp. (the “Company”), its officers and its employees (and the directors, officers and employees of any subsidiary of the Company; all of the foregoing being referred to herein from time to time as “team members”) of Company securities is encouraged, so long as suc |
|
| December 13, 2024 |
Exhibit 10.1 Amendment to Transition, Separation, and Release Agreement This amendment, delivered on December 9, 2024, confirms the following understandings and agreements between AdaptHealth Corp. (the “Company”) and Shaw Rietkerk (hereinafter referred to as “you” or “your”). WHEAREAS, the parties entered a “Transition and Separation Agreement” on August 21, 2024, and have agreed to amend section |
|
| December 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| November 14, 2024 |
AHCO / AdaptHealth Corp. / Flynn James E Passive Investment SC 13G/A 1 e664017sc13ga-adapthealth.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 4)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 00653Q102 (CUSIP Number) Sep |
|
| November 13, 2024 |
EX-99.1 2 ef20038552ex1.htm EXHIBIT 1 EXHIBIT 1 Joint Filing Agreement This will confirm the agreement by and among all the undersigned that the Schedule 13G filed on or about this date and any amendments thereto with respect to the beneficial ownership by the undersigned of ordinary shares of AdaptHealth Corp. is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1) |
|
| November 13, 2024 |
AHCO / AdaptHealth Corp. / Jefferies Financial Group Inc. - SC 13G Passive Investment SC 13G 1 ef20038552sc13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 00653Q102 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| November 5, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 5, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) ( |
|
| November 5, 2024 |
] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as s |
|
| November 5, 2024 |
ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2024 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2024 RESULTS PLYMOUTH MEETING, Pa. – November 5, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third |
|
| October 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| October 30, 2024 |
Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 30th day of October 2024 (the “Effective Date”), by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Albert Prast (“Executive”). W I T N E S S E T H : WHEREAS, Executive is currently employed by the Company as its Chief Technology Officer; a |
|
| October 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| October 22, 2024 |
Form of Indemnification Agreement Exhibit 10.1 ADAPTHEALTH CORP INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is made as of October 16, 2024, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and [·] (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement. Certain cap |
|
| October 22, 2024 |
Exhibit 99.1 ADAPTHEALTH CORP. FOR IMMEDIATE RELEASE AdaptHealth Appoints Diana Nole to Board of Directors PLYMOUTH MEETING, Pa. – October 17, 2024 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment |
|
| October 1, 2024 |
October 1, 2024 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| September 30, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fi |
|
| September 30, 2024 |
NOTICE OF EXPIRATION DATE TO THE HOLDERS OF ADAPTHEALTH CORP. PRIVATE PLACEMENT WARRANTS Exhibit 99.1 September 24, 2024 NOTICE OF EXPIRATION DATE TO THE HOLDERS OF ADAPTHEALTH CORP. PRIVATE PLACEMENT WARRANTS NOTICE IS HEREBY GIVEN by AdaptHealth Corp., a Delaware corporation (the “Company”), pursuant the Warrant Agreement, dated as of February 15, 2018 (the “Warrant Agreement”), by and among, the Company and Continental Stock Transfer & Trust Company, a New York corporation, as warr |
|
| September 16, 2024 |
Exhibit 10.1 Execution Version FOURTH AMENDMENT dated as of September 13, 2024 to the CREDIT AGREEMENT dated as of January 20, 2021 among ADAPTHEALTH INTERMEDIATE HOLDCO LLC as Intermediate Holdings, ADAPTHEALTH LLC, as Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO FROM TIME TO TIME, as the Guarantors, THE LENDERS PARTY HERETO, and REGIONS BANK, as Administrativ |
|
| September 16, 2024 |
Exhibit 99.1 Contacts AdaptHealth Corp. Jason Clemens, CFA Chief Financial Officer Investor Relations ICR Westwicke [email protected] AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity and Reduced Cost of Debt September 16, 2024 8:00 AM Eastern Daylight Time PLYMOUTH MEETING, Pa.-(BUSINESS WIRE)-AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” |
|
| September 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fi |
|
| August 26, 2024 |
Transition Agreement by and between AdaptHealth Corp. and Shaw Rietkerk, dated August 21, 2024. Exhibit 10.2 Execution Version TRANSITION, SEPARATION AND RELEASE AGREEMENT This Transition, Separation and Release Agreement (this “Agreement”), delivered on August 15, 2024 (the “Offer Date”), confirms the following understandings and agreements between AdaptHealth Corp. (the “Company”) and Shaw Rietkerk (hereinafter referred to as “you” or “your”). WHEREAS, the parties entered into that certain |
|
| August 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| August 26, 2024 |
Employment Agreement by and between AdaptHealth Corp. and Toby Scott Barnhart, dated August 1, 2024. Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 1st day of August 2024, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Toby Scott Barnhart (“Executive”). W I T N E S S E T H : WHEREAS, the Company desires to employ Executive and to enter into this Agreement embodying the te |
|
| August 26, 2024 |
AdaptHealth Corp. Announces New Chief Operating Officer Exhibit 99.1 Contacts AdaptHealth Corp. Jason Clemens, CFA Chief Financial Officer [email protected] AdaptHealth Corp. Announces New Chief Operating Officer August 26, 2024 7:30 AM Eastern Daylight Time PLYMOUTH MEETING, Pa.-(BUSINESS WIRE)-AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including hom |
|
| August 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| August 6, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 6, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Co |
|
| August 6, 2024 |
ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2024 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2024 RESULTS PLYMOUTH MEETING, Pa. – August 6, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second |
|
| August 6, 2024 |
Exhibit 3.2 SECOND AMENDED AND RESTATED BY LAWS OF ADAPTHEALTH CORP. (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation’s regis |
|
| August 6, 2024 |
] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specif |
|
| July 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 3, 2024 |
Exhibit 10.1 TRANSITION, SEPARATION AND RELEASE AGREEMENT This Transition, Separation and Release Agreement (this “Agreement”), delivered on June 27, 2024 (the “Offer Date”), confirms the following understandings and agreements between AdaptHealth Corp. (the “Company”), and Joshua Parnes (hereinafter referred to as “you” or “your”). WHEREAS, following discussions initiated by the Chief Executive O |
|
| July 3, 2024 |
ADAPTHEALTH CORP. ANNOUNCES CHANGES TO BOARD OF DIRECTORS AND MANAGEMENT Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES CHANGES TO BOARD OF DIRECTORS AND MANAGEMENT PLYMOUTH MEETING, Pa. – July 2, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today the appointment of |
|
| June 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 21, 2024 |
Amended and Restated 2019 Stock Incentive Plan of the Company. Exhibit 10.1 AdaptHealth Corp. Second Amended and Restated 2019 Stock Incentive Plan (Effective as of June 20, 2024) 1. Purpose. The purpose of the Plan is to assist the Company in attracting, retaining, motivating, and rewarding certain employees, officers, directors, and consultants of the Company and its Affiliates and promoting the creation of long-term value for stockholders |
|
| June 21, 2024 |
Exhibit 3.1 FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ADAPTHEALTH CORP. June 20, 2024 AdaptHealth Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “AdaptHealth Corp.” The Corporation was originally incorporated under the name “DFB HEALTHCARE ACQUISITIONS CORP. |
|
| June 20, 2024 |
As filed with the Securities and Exchange Commission on June 20, 2024 As filed with the Securities and Exchange Commission on June 20, 2024 Registration No. |
|
| June 20, 2024 |
Calculation of Filing Fee Table. Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) ADAPTHEALTH CORP. |
|
| June 11, 2024 |
EX-99.2 2 exhibit99-2.htm EXHIBIT 99.2 Everest Hill Group Inc. & Affiliates Schedule 13D/A Schedule A Transactions between August 17, 2023 and March 24, 2024 Reporting Persons: Everest Hill Group Inc. and all beneficial owner affiliates as reported on the Schedule 13D/A to which this Schedule A appears an exhibit. Date Buy/Sell No. of Shares Price/Share 8/17/2023 Buy 300,000 11.4999 9/15/2023 Buy |
|
| June 11, 2024 |
AHCO / AdaptHealth Corp. / Everest Hill Group Inc. - FORM SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Everest Hill Group Inc. Tropic Isle Building P.O. Box 3331 Road Town, Tortola British Virgin Islands VG1110 With copies to: Travis L. Geri |
|
| May 16, 2024 |
Exhibit 99.1 RESTRICTED STOCK UNIT GRANT NOTICE AND AGREEMENT As an inducement for Holder to enter into employment with AdaptHealth Corp. (the “Company”), and in reliance on Nasdaq Listing Rule 5635(c), the Company hereby grants to Holder the number of Restricted Stock Units set forth below, each Restricted Stock Unit being a notional unit representing the right to receive one share of Stock (the |
|
| May 16, 2024 |
As filed with the Securities and Exchange Commission on May 16, 2024 As filed with the Securities and Exchange Commission on May 16, 2024 Registration No. |
|
| May 16, 2024 |
Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) ADAPTHEALTH CORP. |
|
| May 7, 2024 |
] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as speci |
|
| May 7, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 7, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Commi |
|
| May 7, 2024 |
Revised Offer of Employment, dated December 18, 2023 between AdaptHealth Corp. and Shaw Rietkerk. Exhibit 10.3 December 18, 2023 Re: Revised Offer of Employment Dear Shaw: It is my pleasure to extend a revised offer of employment with AdaptHealth Corp. Any terms not addressed below will remain the same as those set out in your previous offer of employment. The key terms of this employment offer are as follows: 1.Compensation. a) Base Wages: Effective January 1, 2024, you will be compensated an |
|
| May 7, 2024 |
Revised Offer of Employment, dated September 22, 2023 between AdaptHealth Corp. and Shaw Rietkerk. Exhibit 10.2 September 22, 2023 Re: Revised Offer of Employment Dear Shaw: It is my pleasure to provide documentation for your revised employment agreement terms with AdaptHealth Corp. Any terms not addressed below will remain the same as those set out in your previous offers of employment effective 02/26/2020 and 3/8/23: The key terms are as follows: 1.Compensation. (a)Severance: In the event tha |
|
| May 7, 2024 |
ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2024 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2024 RESULTS PLYMOUTH MEETING, Pa. – May 7, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quart |
|
| May 7, 2024 |
Revised Offer of Employment, dated April 28, 2023, between AdaptHealth Corp. and Shaw Rietkerk. Exhibit 10.1 April 28, 2023 Re: Revised Offer of Employment Dear Shaw: It is my pleasure to provide documentation for your revised employment agreement terms with AdaptHealth Corp. Any terms not addressed below will remain the same as those set out in your previous offer of employment effective 02/26/2020: The key terms are as follows: 1.Compensation. a.Base Compensation. Effective October 2, 2021 |
|
| April 26, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| April 17, 2024 |
Amendment to Employment Agreement between AdaptHealth Corp. and Jason Clemens, dated April 15, 2024. Exhibit 10.3 April 15, 2024 Re: Amendment to Employment Agreement Dear Jason: Reference is made to your employment agreement with AdaptHealth Corp.(the “Company”), dated as of May 1, 2020 (the “Employment Agreement”). Capitalized terms set forth herein will have the meanings set forth in the Employment Agreement. By signing below, you confirm our mutual understanding with respect to the following |
|
| April 17, 2024 |
Exhibit 10.2 AdaptHealth Corp. April 15, 2024 ELECTRONIC DELIVERY Richard Barasch Re: Fifth Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of June 26, 2023 (the “Letter Agreement”), as amended by certain letter agreements by and between you and the Company, dated as of August 29, 2023, |
|
| April 17, 2024 |
Employment Agreement by and between AdaptHealth Corp. and Suzanne Foster, dated April 10, 2024. Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 10 day of April 2024, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Suzanne Foster (“Executive”). W I T N E S S E T H : WHEREAS, the Company desires to employ Executive and to enter into this Agreement embodying the terms of such emplo |
|
| April 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2024 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 17, 2024 |
ADAPTHEALTH APPOINTS SUZANNE FOSTER AS CHIEF EXECUTIVE OFFICER Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH APPOINTS SUZANNE FOSTER AS CHIEF EXECUTIVE OFFICER PLYMOUTH MEETING, Pa. – April 17, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Director |
|
| April 12, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| March 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 3, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Com |
|
| March 4, 2024 |
Exhibit 10.1 AdaptHealth Corp. March 3, 2024 ELECTRONIC DELIVERY Richard Barasch Re: Fourth Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of June 26, 2023 (the “Letter Agreement”), as amended by certain letter agreements by and between you and the Company, dated as of August 29, 2023, |
|
| February 27, 2024 |
*5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K *5 '\]''''''''''''''''''''''''''''''''''''''''''''''']'3333333333333333333 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 27, 2024 |
Stipulation and Agreement of Settlement, dated as of February 26, 2024. Exhibit 10.31 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA DELAWARE COUNTY EMPLOYEES RETIREMENT SYSTEM and BUCKS COUNTY EMPLOYEES’ RETIREMENT SYSTEM, Individually and on Behalf of All Others Similarly Situated, Plaintiffs, vs. ADAPTHEALTH CORP. f/k/a DFB HEALTHCARE ACQUISITIONS CORP., LUKE MCGEE, STEPHEN P. GRIGGS, JASON CLEMENS, FRANK J. MULLEN, RICHARD BARASCH, JOSHUA PARNES, AL |
|
| February 27, 2024 |
AdaptHealth Corp. Policy for the Recovery of Erroneously Awarded Compensation Exhibit 97.1 ADAPTHEALTH CORP. POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION 1.Purpose. The purpose of this Policy is to describe the circumstances in which Executives will be required to repay or return Erroneously Awarded Compensation to members of the Company Group. Each Executive shall be required to sign and return to the Company the Acknowledgement Form attached hereto as Exhib |
|
| February 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 27, 2024 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) |
|
| February 27, 2024 |
Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 RESULTS AND PROVIDES INITIAL 2024 OUTLOOK PLYMOUTH MEETING, Pa. – February 27, 2024 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services |
|
| February 27, 2024 |
Exhibit 21.1 The Company’s principal subsidiaries as of December 31, 2023 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. Subsidiaries (Alphabetically) State of Inc. ABC Medical, LLC SOUTH CAROLINA Absolute Respiratory Care, LLC RHODE ISLAND Access Medical, LLC MICHIGAN Accu |
|
| February 27, 2024 |
Exhibit 4.4 DESCRIPTION OF SECURITIES We are incorporated in the State of Delaware. The rights of our stockholders are generally covered by Delaware law and our third amended and restated certificate of incorporation (as amended, “Certificate of Incorporation”) and amended and restated bylaws (as amended, “Bylaws”). The terms of our Common Stock (as defined below) are therefore subject to Delaware |
|
| February 13, 2024 |
AHCO / AdaptHealth Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0181-adapthealthcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: AdaptHealth Corp Title of Class of Securities: Common Stock CUSIP Number: 00653Q102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate th |
|
| February 12, 2024 |
AHCO / AdaptHealth Corp. / Flynn James E Passive Investment SC 13G/A 1 e619239sc13ga-adapthealth.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 3)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 00653Q102 (CUSIP Number) Dec |
|
| December 27, 2023 |
Exhibit 10.1 AdaptHealth Corp. December 21, 2023 ELECTRONIC DELIVERY Richard Barasch Re: Third Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of June 26, 2023 (the “Letter Agreement”), as amended by certain letter agreements by and between you and the Company, dated as of August 29, 20 |
|
| December 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 21, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) |
|
| December 13, 2023 |
As filed with the Securities and Exchange Commission on December 13, 2023 As filed with the Securities and Exchange Commission on December 13, 2023 Registration No. |
|
| December 13, 2023 |
Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) ADAPTHEALTH CORP. |
|
| November 22, 2023 |
Exhibit 10.1 AdaptHealth LLC Non-qualified Deferred Compensation Plan Effective January 1st, 2024 IMPORTANT NOTE This document has not been approved by the Department of Labor, Internal Revenue Service, or any other governmental entity. An adopting Employer must determine whether the Plan is subject to the Federal securities laws and the securities laws of the various states. An adopting Employer |
|
| November 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 17, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) |
|
| November 7, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 7, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) ( |
|
| November 7, 2023 |
ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2023 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2023 RESULTS PLYMOUTH MEETING, Pa. – November 7, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as spe |
|
| October 31, 2023 |
Exhibit 10.1 ADAPTHEALTH CORP. October 26, 2023 ELECTRONIC DELIVERY Richard Barasch Re: Second Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of June 26, 2023 (the “Letter Agreement”), as amended by that certain letter agreement by and between you and the Company, dated as of August 29 |
|
| October 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 26, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) ( |
|
| September 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 19, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) |
|
| August 29, 2023 |
Exhibit 10.1 AdaptHealth Corp. August 29, 2023 ELECTRONIC DELIVERY Richard Barasch Re: Extension of Transition Date Dear Richard, Reference is made to that certain letter agreement by and between you and AdaptHealth Corp., dated as of June 26, 2023 (the “Letter Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Letter Agreemen |
|
| August 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 29, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (C |
|
| August 28, 2023 |
Everest Hill Group Inc. & Affiliates Schedule 13D/A Schedule A Transactions between November 11, 2022 and August 9, 2023 Reporting Persons: Everest Hill Group Inc. and all beneficial owner affiliates as reported on the Schedule 13D/A to which this Schedule A appears an exhibit. Date Buy/Sell No. of Shares Price/Share 11/11/2022 Sell 23,583 $23.000 1/10/2023 Sell 200,000 $20.384 1/12/2023 Sell 340, |
|
| August 28, 2023 |
AHCO / AdaptHealth Corp / Everest Hill Group Inc. - FORM SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Everest Hill Group Inc. Tropic Isle Building P.O. Box 3331 Road Town, Tortola British Virgin Islands VG1110 With copies |
|
| August 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 16, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (C |
|
| August 11, 2023 |
AHCO / AdaptHealth Corp / Peloton Equity AeroCare SPV I, L.P. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Theodore B. Lundberg Peloton Equity, LLC 66 Field Point Road, 2nd Floor Greenwich, CT 06830 (203) 532-8011 (Name, Address and |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specifie |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 8, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Co |
|
| August 8, 2023 |
ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2023 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2023 RESULTS PLYMOUTH MEETING, Pa. – August 8, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second |
|
| July 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 27, 2023 |
Exhibit 10.1 Execution Copy EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 24th day of July, 2023, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Albert Prast (“Executive”). W I T N E S S E T H : WHEREAS, Executive is currently employed by the Company as its Chief Technology Officer; and WHEREAS, Executive is a p |
|
| June 27, 2023 |
Exhibit 99.1 AdaptHealth Appoints Crispin Teufel as New Chief Executive Officer PLYMOUTH MEETING, Pa. – June 27, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, announced today that its Board of Directors has named Crispin |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 27, 2023 |
Exhibit 10.2 ADAPTHEALTH CORP. June 26, 2023 ELECTRONIC DELIVERY Richard Barasch Re: Terms of Employment (Interim Chief Executive Officer) Dear Richard, On behalf of the Board of Directors (the “Board”) of AdaptHealth Corp. (the “Company”), I am pleased to present you with this letter (this “Letter”) setting forth the terms and conditions of your appointment as the Company’s Interim Chief |
|
| June 27, 2023 |
Employment Agreement between AdaptHealth Corp. and Crispin Teufel, dated June 22, 2023. Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 22nd day of June 2023, by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Crispin Teufel (“Executive”). W I T N E S S E T H : WHEREAS, the Company desires to employ Executive and to enter into this Agreement embodying the terms of such empl |
|
| June 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 16, 2023 |
AHCO / AdaptHealth Corp / Peloton Equity AeroCare SPV I, L.P. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Theodore B. Lundberg Peloton Equity, LLC 66 Field Point Road, 2nd Floor Greenwich, CT 06831 (203) 532-8011 (Name, Address and |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: o Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| May 9, 2023 |
Exhibit 10.1 THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of March 31, 2023 (the “Third Amendment Effective Date”), to the Credit Agreement referenced below is by and among ADAPTHEALTH INTERMEDIATE HOLDCO LLC, a Delaware limited liability company (“Intermediate Holdings”), ADAPTHEALTH LLC, a Delaware limited liability company (the “Borro |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registrant as specifi |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 9, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) (Commi |
|
| May 9, 2023 |
ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2023 RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2023 RESULTS PLYMOUTH MEETING, Pa. – May 9, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quart |
|
| May 9, 2023 |
Offer Letter, dated as of January 15, 2018, by and between the Company and Christopher J. Joyce. QMES January 15, 2018 Christopher J. Joyce Re: QMES Offer of Employment Dear Chris: On behalf of QMES, I am pleased to confirm our offer to you the position of General Counsel, reporting directly to me. The key terms of this employment offer (contingent on successfully passing a background check) are as follows: Base Salary and Annual Performance Bonus As General Counsel, you shall be paid an annu |
|
| May 9, 2023 |
Transition Letter Agreement, between AdaptHealth Corp. and Stephen P. Griggs, dated May 8, 2023. Exhibit 10.1 ADAPTHEALTH CORP. May 8, 2023 Stephen P. Griggs via electronic delivery Re: Transition Agreement Dear Steve, Reference is made to that certain Employment Agreement by and between you and AdaptHealth Corp. (the “Company”), dated as of February 1, 2021 (the “Employment Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in |
|
| May 9, 2023 |
Exhibit 99.1 AdaptHealth Announces Stephen Griggs Will Step Down as CEO at the End of Second Quarter Board Has Initiated a Search for a Successor Plymouth Meeting, PA – May 9, 2023 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| March 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 28, 2023 |
Exhibit 21.1 The Company’s principal subsidiaries as of December 31, 2022 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. Subsidiaries (Alphabetically) State of Inc. ABC Medical, LLC SOUTH CAROLINA Absolute Respiratory Care, LLC RHODE ISLAND Access Medical, LLC MICHIGAN Accu |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38399 AdaptHealth Corp. (Exact name of registra |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 27, 2023 Date of Report (date of earliest event reported) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation or organization) |
|
| February 27, 2023 |
ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 RESULTS AND UPDATES 2023 OUTLOOK Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 RESULTS AND UPDATES 2023 OUTLOOK PLYMOUTH MEETING, Pa. – February 27, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announc |
|
| February 10, 2023 |
AHCO / Adapthealth Corp / Flynn James E Passive Investment SC 13G/A 1 e618269sc13ga-adapthealth.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 00653Q102 (CUSIP Number) Dec |
|
| February 9, 2023 |
AHCO / Adapthealth Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: AdaptHealth Corp. Class A Title of Class of Securities: Common Stock CUSIP Number: 00653Q102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is fi |
|
| January 11, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH PROVIDES Full-year 2023 Guidance AND Preliminary Commentary on Fourth Quarter 2022 REsults PLYMOUTH MEETING, Pa. – January 10, 2023 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, |
|
| January 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2023 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| December 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| November 8, 2022 |
March 31, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents March 31, ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 8, 2022 |
ADAPTHEALTH CORP. Announces THIRD Quarter 2022 RESULTS AND UPDATES 2022 OUTLOOK Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. Announces THIRD Quarter 2022 RESULTS AND UPDATES 2022 OUTLOOK PLYMOUTH MEETING, Pa. ? November 8, 2022 - AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financi |
|
| November 7, 2022 |
AHCO / Adapthealth Corp / Everest Hill Group Inc. - FORM SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Everest Hill Group Inc. Tropic Isle Building P.O. Box 3331 Road Town, Tortola British Virgin Islands VG1110 With copies |
|
| November 7, 2022 |
Everest Hill Group Inc. & Affiliates Schedule 13D/A Schedule A Transactions between August 10, 2022 and November 2, 2022 Reporting Persons: Everest Hill Group Inc. and all beneficial owner affiliates as reported on the Schedule 13D/A to which this Schedule A appears an exhibit. Date Buy/Sell No. of Shares Price/Share 08/10/2022 Sell 159,000 $23.000 08/11/2022 Sell 113,139 $23.500 08/11/2022 Sell 4 |
|
| October 7, 2022 |
October 7, 2022 Jason Clemens Chief Financial Officer AdaptHealth Corp. 220 W. Germantown Pike, Suite 250 Plymouth Meeting, PA 19462 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Christine Torney and Vanessa Robertson Re: AdaptHealth Corp. Form 10-K for the Fiscal Year Ended Decembe |
|
| August 9, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 9, 2022 |
March 31, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents March 31, ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 9, 2022 |
ADAPTHEALTH REPORTS SECOND Quarter 2022 Results Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH REPORTS SECOND Quarter 2022 Results PLYMOUTH MEETING, Pa. ? August 9, 2022 - AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter |
|
| June 23, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 16, 2022 |
Exhibit 99.1 JOINT FILING AGREEMENT The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934. Dated: June 16, 2022 SKYKNIGHT A |
|
| June 16, 2022 |
AHCO / Adapthealth Corp / SkyKnight Aero Holdings, LLC - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* AdaptHealth Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Matthew Ebbel SkyKnight Capital One Letterman Drive Building C, Suite 3-950 San Francisco, CA 94129 (415) 914-0788 (Name, Address and T |
|
| May 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 12, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 12, 2022 |
Exhibit 10.1 CONSENT AGREEMENT THIS CONSENT AGREEMENT (this ?Agreement?) dated as of May 9, 2022, related to the Credit Agreement referenced below is by and among ADAPTHEALTH INTERMEDIATE HOLDCO LLC, a Delaware limited liability company (?Intermediate Holdings?), ADAPTHEALTH LLC, a Delaware limited liability company (the ?Borrower?), certain Subsidiaries of the Borrower from time to time party the |
|
| May 10, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH REPORTS FIRST Quarter 2022 Results, UPDATES 2022 guidance, AND ANNOUNCES $200 million SHARE REPURCHASE program PLYMOUTH MEETING, Pa. ? May 10, 2022 - AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and re |
|
| May 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 10, 2022 |
Exhibit 10.2 ? EMPLOYMENT AND NON-COMPETITION AGREEMENT ? THIS EMPLOYMENT AND NON-COMPETITION AGREEMENT (this ?Agreement?) is made and entered into as of the 21st day of April, 2014, by and between Aerocare Holdings, Inc., a Delaware Company (the ?Company?), and Albert Prast (the ?Executive?). RECITALS WHEREAS, the Executive desires to serve as the Chief Technology Officer of the Company and the C |
|
| May 10, 2022 |
Exhibit 10.1 EMPLOYMENT AND NON-COMPETITION AGREEMENT THIS EMPLOYMENT AND NON-COMPETITION AGREEMENT (this ?Agreement?) is made and entered into as of the 1st day of January, 2013, by and between Aerocare Holdings, Inc., a Delaware Company (the ?Company?), and Daniel C. Bunting (the ?Executive?). RECITALS WHEREAS, the Executive desires to serve as the Vice President of Operations and Chief Operatin |
|
| May 10, 2022 |
une UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents une ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State |
|
| March 1, 2022 |
Exhibit 21.1 ? The Company?s principal subsidiaries as of December 31, 2021 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. ? Subsidiaries (Alphabetically) State of Inc. ABC Medical, LLC ? SOUTH CAROLINA Absolute Respiratory Care, LLC ? RHODE ISLAND Access Medical, LLC ? MIC |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 24, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2022 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 24, 2022 |
ADAPTHEALTH REPORTS Fourth Quarter and Full-Year 2021 Results And UPDATES 2022 guidance Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH REPORTS Fourth Quarter and Full-Year 2021 Results And UPDATES 2022 guidance PLYMOUTH MEETING, Pa. ? February 24, 2022 - AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced toda |
|
| February 11, 2022 |
AHCO / Adapthealth Corp / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| February 9, 2022 |
AHCO / Adapthealth Corp / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: AdaptHealth Corp. Class A Title of Class of Securities: Common Stock CUSIP Number: 00653Q102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) |
|
| November 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 9, 2021 |
une UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents une ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| November 4, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS, RAISES FULL-YEAR 2021 GUIDANCE, AND PROVIDES FULL-YEAR 2022 GUIDANCE Plymouth Meeting, PA ? November 4, 2021 ? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or ?the Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplie |
|
| October 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fi |
|
| October 4, 2021 |
ADAPTHEALTH CORP. ANNOUNCES APPOINTMENT OF GREG BELINFANTI AS DIRECTOR Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES APPOINTMENT OF GREG BELINFANTI AS DIRECTOR Plymouth Meeting, PA ? September 30, 2021 ? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Greg Belin |
|
| August 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| August 20, 2021 |
Execution Version Exhibit 4.1 SENIOR NOTES INDENTURE Dated as of August 19, 2021 Among ADAPTHEALTH LLC THE GUARANTORS LISTED ON THE SIGNATURE PAGES HERETO and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee 5.125% SENIOR NOTES DUE 2030 TABLE OF CONTENTS Page Article 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section 1.02 Other Definitions 25 Section 1.03 R |
|
| August 20, 2021 |
Exhibit 10.1 SECOND AMENDMENT THIS SECOND AMENDMENT (this ?Amendment?) dated as of August 16, 2021, to the Credit Agreement referenced below is by and among ADAPTHEALTH INTERMEDIATE HOLDCO LLC, a Delaware limited liability company (?Intermediate Holdings?), AdaptHealth LLC, a Delaware limited liability company (the ?Borrower?), certain Subsidiaries of the Borrower from time to time party thereto, |
|
| August 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K AdaptHealth Corp. (Exact name of registrant as specified in its charter) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 16, 2021 Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| August 11, 2021 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP. Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP. The following unaudited pro forma condensed combined financial information presents the unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2021 and 2020, and the year ended December 31, 2020 based upon the combined historical financial statements of AdaptHea |
|
| August 11, 2021 |
Exhibit 99.2 Excerpts from AdaptHealth LLC?s Confidential Preliminary Offering Memorandum dated August 11, 2021. Non-GAAP financial measures We refer to the terms EBITDA, Adjusted EBITDA, Adjusted EBITDA (pro forma, as adjusted) and Adjusted EBITDA less Patient Equipment Capex (pro forma, as adjusted) (each as defined in ?Summary?Summary historical and pro forma financial data?) in various places |
|
| August 11, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| August 11, 2021 |
AdaptHealth Announces Proposed Offering of $550 Million Senior Notes Due 2030 Exhibit 99.1 AdaptHealth Announces Proposed Offering of $550 Million Senior Notes Due 2030 Plymouth Meeting, PA ? August 10, 2021? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its subsidiary, AdaptHealth L |
|
| August 6, 2021 |
As filed with the Securities and Exchange Commission on August 6, 2021 As filed with the Securities and Exchange Commission on August 6, 2021 Registration No. |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 5, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 5, 2021 |
ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS EX-99.1 2 tm2123465d2ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS Plymouth Meeting, PA – August 5, 2021 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related servi |
|
| July 29, 2021 |
Exhibit 10.1 AdaptHealth Corp. Amended and Restated 2019 Stock Incentive Plan (Effective as of July 27, 2021) 1.????????????????? Purpose. ? The purpose of the Plan is to assist the Company in attracting, retaining, motivating, and rewarding certain employees, officers, directors, and consultants of the Company and its Affiliates and promoting the creation of long-term value for stockholders of th |
|
| July 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 29, 2021 |
Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ADAPTHEALTH CORP. July 28, 2021 AdaptHealth Corp., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is ?AdaptHealth Corp.? The Corporation was originally incorporated under the name ?DFB HEALTHCARE ACQUISITIONS CORP.? |
|
| July 14, 2021 |
July 14, 2021 VIA EDGAR Office of Life Sciences United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| July 6, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ? Washington, D. |
|
| June 29, 2021 |
Exhibit 99.1 AEROCARE HOLDINGS, INC. AND SUBSIDIARIES Consolidated Financial Statements Years ended December 31, 2020 and 2019 AEROCARE HOLDINGS, INC. AND SUBSIDIARIES Table of Contents Page Independent Auditors? Report 1 Consolidated Financial Statements Consolidated Balance Sheets 2 Consolidated Statements of Income 3 Consolidated Statements of Comprehensive Income 4 Consolidated Statements of C |
|
| June 29, 2021 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2021 (December 14, 2020) AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdicti |
|
| June 29, 2021 |
As filed with the Securities and Exchange Commission on June 28, 2021 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 28, 2021 Registration No. |
|
| June 29, 2021 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP. Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP. The following unaudited pro forma condensed combined financial information presents the unaudited pro forma condensed combined statements of operations for the three months ended March 31, 2021 and the year ended December 31, 2020 based upon the combined historical financial statements of AdaptHealth Cor |
|
| June 22, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ? Washington, D. |
|
| June 15, 2021 |
10.1 Memorandum of Understanding for Settlement Exhibit 10.1 MEMORANDUM OF UNDERSTANDING (?MOU?) FOR SETTLEMENT BETWEEN ADAPTHEALTH CORP. AND LUKE MCGEE Dated: June 11, 2021 Parties Luke McGee (?LM?) and AdaptHealth Corp. (together with its subsidiaries, the ?Company?). Termination of Employment Reference is made to the Employment Agreement, dated March 20, 2019, by and between AdaptHealth Holdings LLC, a Delaware limited liability company, and |
|
| June 15, 2021 |
AdaptHealth Appoints Stephen Griggs Chief Executive Officer Exhibit 99.1 PRESS RELEASE AdaptHealth Appoints Stephen Griggs Chief Executive Officer Plymouth Meeting, PA ? June 14, 2021 ? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?) announced today that its Board of Directors (the ?Board?) has appointed Stephen Griggs as Chief Executive Officer of the Company, effective immediately. Mr. Griggs, who is also a member of the Board, joined A |
|
| June 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) Of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 4, 2021 |
As filed with the Securities Exchange Commission on June 4, 2021 As filed with the Securities Exchange Commission on June 4, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ADAPTHEALTH CORP. (Exact name of registrant as specified in its charter) Delaware 82-3677704 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Ide |
|
| May 21, 2021 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. |
|
| May 10, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 6, 2021 |
ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS Plymouth Meeting, PA ? May 6, 2021 ? AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies and related services, announced today financial results for the fir |
|
| May 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 30, 2021 |
Exhibit 21.1 ? The Company?s principal subsidiaries as of December 31, 2020 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. ? Subsidiaries (Alphabetically) State of Inc. ActivStyle Holding Company ? DELAWARE ActivStyle, LLC ? MINNESOTA AdaptHealth Missouri LLC ? MISSOURI Ada |
|
| April 30, 2021 |
Table of Contents ? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| April 30, 2021 |
Employment Agreement, dated August 3, 2020, by and between the Company and Shaw Rietkerk. Exhibit 10.14 August 3, 2020 Mr. Shaw Rietkerk ? ? Re: Employment Letter Dear Shaw, On behalf of AdaptHealth LLC (the ?Company?), I am pleased to confirm this continued offer of employment to you as Chief Operating Officer of the Company on the terms and conditions set forth below. ? ? Responsibilities Your responsibilities will continue to include (i) leadership, direction and execution of the Co |
|
| April 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 30, 2021 |
? Exhibit 3.4 ? CERTIFICATE OF CORRECTION OF THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ADAPTHEALTH CORP. ? AdaptHealth Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?Corporation?), does hereby certify: 1. The name of the Corporation is AdaptHealth Corp. 2. The Second Amended and Restated Certificat |
|
| April 29, 2021 |
Exhibit 10.1 FIRST INCREMENTAL FACILITY AMENDMENT dated as of April 23, 2021 to the CREDIT AGREEMENT dated as of January 20, 2021 among ADAPTHEALTH INTERMEDIATE HOLDCO LLC as Intermediate Holdings, ADAPTHEALTH LLC, as Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO FROM TIME TO TIME, as the Guarantors, THE LENDERS PARTY HERETO, and REGIONS BANK, as Administrative Agent and Collateral A |
|
| April 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N |
|
| April 13, 2021 |
AdaptHealth Corp.’s Board of Directors’ Statement on Co-Chief Executive Officer Luke McGee Exhibit 99.1 AdaptHealth Corp.?s Board of Directors? Statement on Co-Chief Executive Officer Luke McGee Plymouth Meeting, PA ? April 13, 2021 ? The Board of Directors of AdaptHealth Corp. (NASDAQ: AHCO) (?AdaptHealth? or the ?Company?) today issued the following statement: AdaptHealth Corp. has learned that authorities in Denmark have formally charged Co-Chief Executive Officer Luke McGee with all |
|
| April 13, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) Of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 16, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 16, 2021 |
Exhibit 21.1 ? The Company?s principal subsidiaries as of December 31, 2020 are listed below. All other subsidiaries of the Company, if considered in the aggregate as a single affiliate, would not constitute a significant subsidiary of the Company. ? Subsidiaries (Alphabetically) State of Inc. ActivStyle Holding Company ? DELAWARE ActivStyle, LLC ? MINNESOTA AdaptHealth Missouri LLC ? MISSOURI Ada |
|
| March 15, 2021 |
SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AdaptHealth Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Matthew Ebbel SkyKnight Capital One Letterman Drive Building C, Suite 3-950 San Francisco, CA 94129 (415) 914-0788 (Name, |
|
| March 15, 2021 |
SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AdaptHealth Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Theodore B. Lundberg Peloton Equity, LLC 10 Glenville Street Greenwich, CT 06831 (203) 532-8011 (Name, Address and Teleph |
|
| March 15, 2021 |
Exhibit 99.1 JOINT FILING AGREEMENT The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934. Dated: March 15, 2021 SKYKNIGHT |
|
| March 15, 2021 |
Joint Filing Agreement (filed herewith). EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934. Dated: March 15, 2021 PE |
|
| March 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| March 4, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| March 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| March 4, 2021 |
ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS Plymouth Meeting, PA – March 4, 2021 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centric and technology-enabled chronic disease management solutions including home healthcare equipment, medical supplies to the home and re |
|
| February 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| February 2, 2021 |
Exhibit 10.1 CREDIT AGREEMENT dated as of January 20, 2021 among AdaptHealth Intermediate Holdco LLC, as Intermediate Holdings, AdaptHealth LLC, as Borrower, CERTAIN Subsidiaries OF THE BORROWER PARTY HERETO FROM TIME TO TIME, as Guarantors, THE LENDERS PARTY HERETO, REGIONS BANK, as Administrative Agent and Collateral Agent, CITIZENS BANK, N.A., Truist bank, FIFTH THIRD BANK, NATIONAL ASSOCIATION |
|
| February 2, 2021 |
ADAPTHEALTH CORP. CLOSES PREVIOUSLY ANNOUNCED ACQUISITION OF AEROCARE HOLDINGS INC. Exhibit 99.1 ADAPTHEALTH CORP. CLOSES PREVIOUSLY ANNOUNCED ACQUISITION OF AEROCARE HOLDINGS INC. Plymouth Meeting, PA – February 1, 2021 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, announced today that it has closed the previously announced acquisition o |
|
| February 2, 2021 |
Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this [●] day of [●], 202[●], by and between AdaptHealth Corp., a Delaware corporation (the “Company”), and Stephen P. Griggs (“Executive”). W I T N E S S E T H : WHEREAS, Executive is currently employed by AeroCare Holdings, Inc., a Delaware corporation (“AeroCare”), as its Chief Executive |
|
| January 20, 2021 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| January 12, 2021 |
Exhibit 1.1 Execution Version 8,000,000 Shares of Class A Common Stock AdaptHealth Corp. UNDERWRITING AGREEMENT January 5, 2021 DEUTSCHE BANK SECURITIES INC. JEFFERIES LLC As Representatives of the several Underwriters c/o DEUTSCHE BANK SECURITIES INC. 60 Wall Street New York, New York 10005 c/o JEFFERIES LLC 520 Madison Avenue New York, New York 10022 Ladies and Gentlemen: Introductory. AdaptHeal |
|
| January 12, 2021 |
Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2021 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| January 11, 2021 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| January 11, 2021 |
787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 January 11, 2021 VIA EDGAR Office of Life Sciences United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| January 8, 2021 |
Exhibit 4.1 Execution Version SENIOR NOTES INDENTURE Dated as of January 4, 2021 Among ADAPTHEALTH LLC THE GUARANTORS LISTED ON THE SIGNATURE PAGES HERETO and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee 4.625% SENIOR NOTES DUE 2029 TABLE OF CONTENTS Page Article 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section 1.02 Other Definitions 26 Section 1.03 R |
|
| January 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K AdaptHealth Corp. (Exact name of registrant as specified in its charter) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 4, 2021 Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| January 7, 2021 |
8,000,000 Shares AdaptHealth Corp. Class A Common Stock TABLE OF CONTENTS Filed pursuant to Rule 424(b)(5) Registration No. 333-251452 Prospectus Supplement (To Prospectus dated December 30, 2020) 8,000,000 Shares AdaptHealth Corp. Class A Common Stock We are offering 7,250,000 shares of our Class A common stock, par value $0.0001 per share (“Class A Common Stock”). The selling stockholder identified in this prospectus supplement is offering an addit |
|
| January 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* AdaptHealth Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Luke McGee c/o AdaptHealth Corp. 220 West Germantown Pike, Suite 250 Plymouth Meeting, PA 19462 (Name, Address an |
|
| January 4, 2021 |
Subject to Completion, dated January 4, 2021 TABLE OF CONTENTS The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| December 28, 2020 |
December 28, 2020 VIA EDGAR Office of Life Sciences United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D. |
|
| December 22, 2020 |
PRE 14A 1 tm2039015-1pre14a.htm PRE 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for use of the Commission only ( |
|
| December 18, 2020 |
Financial Statements and Exhibits - 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No.1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2020 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) |
|
| December 18, 2020 |
As filed with the Securities and Exchange Commission on December 18, 2020 Registration No. |
|
| December 18, 2020 |
Exhibit 4.10 ADAPTHEALTH CORP. Debt Securities Indenture Dated as of [ ] [ ], as Trustee CROSS-REFERENCE TABLE This Cross-Reference Table is not a part of the Indenture TIA Section Indenture Section 310(a)(1) 7.10 (a)(2) 7.10 (a)(3) N.A. (a)(4) N.A. (a)(5) 7.10 (b) 7.08; 7.10 311(a) 7.11 (b) 7.11 (c) N.A. 312(a) 2.05 (b) 12.03 (c) 12.03 313(a) 7.06 (b)(1) N.A. (b)(2) 7.06 (c) 12.02 (d) 7.06 314(a) |
|
| December 17, 2020 |
Exhibit 99.3 VOTING AGREEMENT This Voting Agreement (this “Agreement”), dated as of November 30, 2020, is entered into by and between Peloton Equity, LLC, a Delaware limited liability company, solely in its capacity as the representative, agent and attorney-in-fact of the Company Equityholders (the “Stockholder Representative”), and the undersigned stockholder of AdaptHealth Corp., a Delaware corp |
|
| December 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* AdaptHealth Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 00653Q102 (CUSIP Number) Luke McGee c/o AdaptHealth Corp. 220 West Germantown Pike, Suite 250 Plymouth Meeting, PA 19462 (Name, Address and |
|
| December 14, 2020 |
AdaptHealth Announces Proposed Offering of $500 Million Senior Notes Due 2029 Exhibit 99.1 AdaptHealth Announces Proposed Offering of $500 Million Senior Notes Due 2029 Plymouth Meeting, PA – December 14, 2020 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, announced today that its subsidiary, AdaptHealth LLC (the “Issuer”), has comme |
|
| December 14, 2020 |
Exhibit 99.3 Aerocare holdings, inc. and subsidiaries Consolidated Financial Statements Years ended December 31, 2019 and 2018 AeroCare Holdings, Inc. and Subsidiaries Table of Contents Page Independent Auditors’ Report 1 Consolidated Financial Statements Consolidated Balance Sheets 3 Consolidated Statements of Income 4 Consolidated Statements of Changes in Stockholders’ Equity (Deficit) 5 Consoli |
|
| December 14, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2020 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission Fil |
|
| December 14, 2020 |
Exhibit 99.2 Excerpts from AdaptHealth LLC’s Confidential Preliminary Offering Memorandum dated December 14, 2020. Non-GAAP financial measures We refer to the terms EBITDA, Adjusted EBITDA, Adjusted EBITDA (pro forma, as adjusted) and Adjusted EBITDA less Patient Equipment Capex (pro forma, as adjusted) (each as defined in “Summary—Summary historical and pro forma financial data”) in various place |
|
| December 14, 2020 |
Exhibit 99.4 Aerocare holdings, inc. and subsidiaries Unaudited Consolidated Interim Financial Statements As of September 30, 2020 and December 31, 2019 And for the Nine Months Ended September 30, 2020 and 2019 AeroCare Holdings, Inc. and Subsidiaries Unaudited Consolidated Interim Financial Statements Table of Contents Page Unaudited Consolidated Interim Financial Statements Consolidated Balance |
|
| December 14, 2020 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP. Exhibit 99.6 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP. The following unaudited pro forma condensed combined financial information presents the unaudited pro forma condensed combined balance sheet as of September 30, 2020 and the unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2020 and 2019 and the year |
|
| December 14, 2020 |
Exhibit 99.5 SOLARA MEDICAL SUPPLIES, LLC UNAUDITED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF JUNE 30, 2020 AND DECEMBER 31, 2019, AND FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2020 AND 2019 SOLARA MEDICAL SUPPLIES UNAUDITED CONSOLIDATED INTERIM FINANCIAL STATEMENTS TABLE OF CONTENTS Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019 1 Consolidated Statements of Operatio |
|
| December 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2020 AdaptHealth Corp. (Exact name of registrant as specified in its charter) Delaware 001-38399 82-3677704 (State or other jurisdiction of incorporation) (Commission File |
|
| December 7, 2020 |
Exhibit 10.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among ADAPTHEALTH CORP., AH APOLLO MERGER SUB INC., AH APOLLO MERGER SUB II INC., AEROCARE HOLDINGS, INC., and PELOTON EQUITY, LLC, as Stockholder Representative December 1, 2020 TABLE OF CONTENTS (continued) ARTICLE I DEFINITIONS 12 1.1 Definitions 12 1.2 Construction 12 ARTICLE II PURCHASE AND SALE; CLOSING; CLOSING DELIVERIES 13 |
|
| December 7, 2020 |
AdaptHealth Corp. Secondary Offering of 2,545,455 shares of Class A Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-239967 PROSPECTUS SUPPLEMENT NO. 11 (to Prospectus dated July 29, 2020) AdaptHealth Corp. Secondary Offering of 2,545,455 shares of Class A Common Stock This prospectus supplement supplements the prospectus dated July 29, 2020 (the “Prospectus”), which forms a part of our registration statement on Form S-1 (No. 333-239967). This prospectus supp |
|
| December 7, 2020 |
Exhibit 4.1 EXECUTION VERSION AMENDMENT TO Amended and Restated REGISTRATION RIGHTS AGREEMENT This AMENDMENT TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Amendment”) is made as of December 1, 2020 (the “Amendment Date”) and amends that certain Amended and Restated Registration Rights Agreement, dated as of July 1, 2020 (the “Existing Agreement”), by and among AdaptHealth Corp., a D |
